Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3279 USD | -1.35% | +1.96% | -45.80% |
Apr. 01 | China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 23 | China Pharma to Conduct 1-For-5 Reverse Stock Split; Shares Fall After-Hours | MT |
Financials (USD)
Sales 2022 | 8.1M | Sales 2023 | 7.01M | Capitalization | 3.99M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -3M | EV / Sales 2022 | 1.44 x |
Net Debt 2022 | 6.73M | Net Debt 2023 | 3.21M | EV / Sales 2023 | 1.03 x |
P/E ratio 2022 |
-1.27
x | P/E ratio 2023 |
-0.66
x | Employees | 231 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 31.16% |
1 day | -1.35% | ||
1 week | +1.96% | ||
Current month | +6.77% | ||
1 month | +0.06% | ||
3 months | -36.33% | ||
6 months | -26.81% | ||
Current year | -45.80% |
Managers | Title | Age | Since |
---|---|---|---|
Zhi Lin Li
CEO | Chief Executive Officer | 71 | 99-01-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Lin Li
CEO | Chief Executive Officer | 71 | 99-01-27 |
Gene Bennett
BRD | Director/Board Member | 76 | 08-01-31 |
Heung Mei Tsui
BRD | Director/Board Member | 67 | 09-04-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.3279 | -1.35% | 6,367,556 |
24-05-16 | 0.3324 | +3.78% | 165,326 |
24-05-15 | 0.3203 | -1.90% | 105,925 |
24-05-14 | 0.3265 | +1.18% | 276,318 |
24-05-13 | 0.3227 | +0.34% | 49,374 |
Delayed Quote Nyse, May 17, 2024 at 04:10 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-45.80% | 4.86M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- CPHI Stock